Literature DB >> 33404696

Radiomic analysis of HTR-DCE MR sequences improves diagnostic performance compared to BI-RADS analysis of breast MR lesions.

Saskia Vande Perre1,2, Loïc Duron2, Audrey Milon1, Asma Bekhouche1, Daniel Balvay2, Francois H Cornelis1,3, Laure Fournier2,4, Isabelle Thomassin-Naggara5,6.   

Abstract

PURPOSE: To assess the diagnostic performance of radiomic analysis using high temporal resolution (HTR)-dynamic contrast enhancement (DCE) MR sequences compared to BI-RADS analysis to distinguish benign from malignant breast lesions.
MATERIALS AND METHODS: We retrospectively analyzed data from consecutive women who underwent breast MRI including HTR-DCE MR sequencing for abnormal enhancing lesions and who had subsequent pathological analysis at our tertiary center. Semi-quantitative enhancement parameters and textural features were extracted. Temporal change across each phase of textural features in HTR-DCE MR sequences was calculated and called "kinetic textural parameters." Statistical analysis by LASSO logistic regression and cross validation was performed to build a model. The diagnostic performance of the radiomic model was compared to the results of BI-RADS MR score analysis.
RESULTS: We included 117 women with a mean age of 54 years (28-88). Of the 174 lesions analyzed, 75 were benign and 99 malignant. Seven semi-quantitative enhancement parameters and 57 textural features were extracted. Regression analysis selected 15 significant variables in a radiomic model (called "malignant probability score") which displayed an AUC = 0.876 (sensitivity = 0.98, specificity = 0.52, accuracy = 0.78). The performance of the malignant probability score to distinguish benign from malignant breast lesions (AUC = 0.876, 95%CI 0.825-0.925) was significantly better than that of BI-RADS analysis (AUC = 0.831, 95%CI 0.769-0.892). The radiomic model significantly reduced false positives (42%) with the same number of missed cancers (n = 2).
CONCLUSION: A radiomic model including kinetic textural features extracted from an HTR-DCE MR sequence improves diagnostic performance over BI-RADS analysis. KEY POINTS: • Radiomic analysis using HTR-DCE is of better diagnostic performance (AUC = 0.876) than conventional breast MRI reading with BI-RADS (AUC = 0.831) (p < 0.001). • A radiomic malignant probability score under 19.5% gives a negative predictive value of 100% while a malignant probability score over 81% gives a positive predictive value of 100%. • Kinetic textural features extracted from HTR-DCE-MRI have a major role to play in distinguishing benign from malignant breast lesions.

Entities:  

Keywords:  Artificial intelligence; Breast; MRI image enhancement; Neoplasms

Year:  2021        PMID: 33404696     DOI: 10.1007/s00330-020-07519-9

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  38 in total

1.  Radiomics of high-grade serous ovarian cancer: association between quantitative CT features, residual tumour and disease progression within 12 months.

Authors:  Stefania Rizzo; Francesca Botta; Sara Raimondi; Daniela Origgi; Valentina Buscarino; Anna Colarieti; Federica Tomao; Giovanni Aletti; Vanna Zanagnolo; Maria Del Grande; Nicoletta Colombo; Massimo Bellomi
Journal:  Eur Radiol       Date:  2018-05-08       Impact factor: 5.315

Review 2.  The current status of breast MR imaging. Part I. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice.

Authors:  Christiane Kuhl
Journal:  Radiology       Date:  2007-08       Impact factor: 11.105

3.  Breast MRI: State of the Art.

Authors:  Ritse M Mann; Nariya Cho; Linda Moy
Journal:  Radiology       Date:  2019-07-30       Impact factor: 11.105

4.  Cancerous breast lesions on dynamic contrast-enhanced MR images: computerized characterization for image-based prognostic markers.

Authors:  Neha Bhooshan; Maryellen L Giger; Sanaz A Jansen; Hui Li; Li Lan; Gillian M Newstead
Journal:  Radiology       Date:  2010-02-01       Impact factor: 11.105

5.  Abbreviated breast MRI combining FAST protocol and high temporal resolution (HTR) dynamic contrast enhanced (DCE) sequence.

Authors:  Audrey Milon; Saskia Vande Perre; Julie Poujol; Isabelle Trop; Edith Kermarrec; Asma Bekhouche; Isabelle Thomassin-Naggara
Journal:  Eur J Radiol       Date:  2019-06-26       Impact factor: 3.528

6.  Angiogenic response of locally advanced breast cancer to neoadjuvant chemotherapy evaluated with parametric histogram from dynamic contrast-enhanced MRI.

Authors:  Yeun-Chung Chang; Chiun-Sheng Huang; Yi-Jui Liu; Jyh-Horng Chen; Yen-Shen Lu; Wen-Yih I Tseng
Journal:  Phys Med Biol       Date:  2004-08-21       Impact factor: 3.609

7.  A novel approach to contrast-enhanced breast magnetic resonance imaging for screening: high-resolution ultrafast dynamic imaging.

Authors:  Ritse M Mann; Roel D Mus; Jan van Zelst; Christian Geppert; Nico Karssemeijer; Bram Platel
Journal:  Invest Radiol       Date:  2014-09       Impact factor: 6.016

8.  Preoperative CT-based radiomics combined with intraoperative frozen section is predictive of invasive adenocarcinoma in pulmonary nodules: a multicenter study.

Authors:  Guangyao Wu; Henry C Woodruff; Sebastian Sanduleanu; Turkey Refaee; Arthur Jochems; Ralph Leijenaar; Hester Gietema; Jing Shen; Rui Wang; Jingtong Xiong; Jie Bian; Jianlin Wu; Philippe Lambin
Journal:  Eur Radiol       Date:  2020-01-31       Impact factor: 5.315

9.  Breast DCE-MRI Kinetic Heterogeneity Tumor Markers: Preliminary Associations With Neoadjuvant Chemotherapy Response.

Authors:  Ahmed Ashraf; Bilwaj Gaonkar; Carolyn Mies; Angela DeMichele; Mark Rosen; Christos Davatzikos; Despina Kontos
Journal:  Transl Oncol       Date:  2015-06       Impact factor: 4.243

10.  Integrated radiomic framework for breast cancer and tumor biology using advanced machine learning and multiparametric MRI.

Authors:  Vishwa S Parekh; Michael A Jacobs
Journal:  NPJ Breast Cancer       Date:  2017-11-14
View more
  4 in total

1.  Diagnostic Efficacy of CT Radiomic Features in Pulmonary Invasive Mucinous Adenocarcinoma.

Authors:  Aizhu Sheng; Pengfei Zhou; Yizhai Ye; Keda Sun; Zhenhua Yang
Journal:  Scanning       Date:  2022-06-25       Impact factor: 1.750

2.  Tumor Diagnosis and Treatment: Imaging Assessment.

Authors:  Filippo Crimì; Federica Vernuccio; Giulio Cabrelle; Chiara Zanon; Alessia Pepe; Emilio Quaia
Journal:  Tomography       Date:  2022-05-30

3.  Radiomics Based on DCE-MRI Improved Diagnostic Performance Compared to BI-RADS Analysis in Identifying Sclerosing Adenosis of the Breast.

Authors:  Mei Ruan; Zhongxiang Ding; Yanna Shan; Shushu Pan; Chang Shao; Wen Xu; Tao Zhen; Peipei Pang; Qijun Shen
Journal:  Front Oncol       Date:  2022-05-12       Impact factor: 5.738

4.  Delta-Radiomics Based on Dynamic Contrast-Enhanced MRI Predicts Pathologic Complete Response in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.

Authors:  Liangcun Guo; Siyao Du; Si Gao; Ruimeng Zhao; Guoliang Huang; Feng Jin; Yuee Teng; Lina Zhang
Journal:  Cancers (Basel)       Date:  2022-07-20       Impact factor: 6.575

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.